pterostilbene low dose
Selected indexed studies
- Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. (Neurobiol Aging, 2012) [PMID:21982274]
- Pterostilbene in Cancer Therapy. (Antioxidants (Basel), 2021) [PMID:33801098]
- Pterostilbene Potentiates the NGF-TrkA Signaling Pathway, Enhancing Differentiation in PC12 Cells. (J Agric Food Chem, 2025) [PMID:40204644]
_Worker-drafted node — pending editorial review._
Connections
pterostilbene low dose helps
pterostilbene low dose protects against
Sources
- Inhibition of UVB radiation-induced tissue swelling and immune suppression by nicotinamide riboside and pterostilbene. (2024) pubmed
- Pterostilbene in Cancer Therapy. (2021) pubmed
- Protective effect of pterostilbene on concanavalin A-induced acute liver injury. (2019) pubmed
- Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability. (2013) pubmed
- Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. (2012) pubmed
- Pterostilbene Potentiates the NGF-TrkA Signaling Pathway, Enhancing Differentiation in PC12 Cells. (2025) pubmed
- Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism. (2012) pubmed
- Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer. (2022) pubmed
- Pterostilbene Induces Apoptosis from Endoplasmic Reticulum Stress Synergistically with Anticancer Drugs That Deposit Iron in Mitochondria. (2024) pubmed
- Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model. (2021) pubmed